Back to News
Market Impact: 0.55

These Analysts Revise Their Forecasts On Dick's Sporting Goods After Q1 Results

DKSFLJPMBCSUBS
Corporate EarningsCorporate Guidance & OutlookM&A & RestructuringAnalyst EstimatesAnalyst InsightsCompany FundamentalsConsumer Demand & Retail
These Analysts Revise Their Forecasts On Dick's Sporting Goods After Q1 Results

Dick's Sporting Goods reported disappointing Q1 2025 results, with adjusted EPS of $3.37 and sales of $3.17 billion, both falling short of analyst expectations of $4.34 and $3.59 billion, respectively, despite a 5.2% year-over-year sales increase. While reaffirming its FY2025 sales and EPS outlook, the company's recent announcement to acquire Foot Locker aims to establish a global leader in sports retail. Following the earnings release, several analysts adjusted their price targets on Dick's, resulting in mixed reactions.

Analysis

Dick's Sporting Goods (DKS) reported a challenging first quarter for FY2025, with adjusted earnings per share of $3.37, significantly missing the analyst consensus estimate of $4.34. Quarterly sales of $3.17 billion also fell short of the Street view of $3.59 billion, despite achieving a 5.2% year-over-year increase. Notwithstanding this underperformance, the company maintained its FY2025 sales forecast between $13.60 billion and $13.90 billion, aligning with analyst expectations of $13.86 billion, and reaffirmed its GAAP EPS outlook of $13.80 to $14.40, inclusive of current tariff impacts. A pivotal strategic announcement was the plan to acquire Foot Locker, a move aimed at establishing a global leader in the sports retail sector. In the trading session following the report, Dick's shares experienced a modest increase of 1.2% to $179.24. Analyst reactions to the earnings were varied regarding price targets: DA Davidson maintained a Buy rating but lowered its price target from $273 to $230; JP Morgan maintained a Neutral stance, reducing its target from $224 to $195; Barclays sustained an Overweight rating and notably raised its target from $217 to $232; and UBS kept a Buy rating while decreasing its target from $260 to $225. This combination of a quarterly miss, reaffirmed annual guidance, a significant M&A initiative, and mixed analyst price target adjustments indicates a complex outlook where near-term performance pressures are counterbalanced by long-term strategic ambitions and management's confidence in its annual projections.